Active repression of antiapoptotic gene expression by RelA(p65) NF-kappa B. (Q40571746)

21 September 2017

Active repression of antiapoptotic gene expression by RelA(p65) NF-kappa B. (English)

1 reference

21 September 2017

0 references

2

1 reference

21 September 2017

Kirsteen J Campbell

1

0 references

author name string

Neil D Perkins

series ordinal

3

1 reference

21 September 2017

1 March 2004

1 reference

21 September 2017

1 reference

21 September 2017

13

1 reference

21 September 2017

6

1 reference

21 September 2017

853-865

1 reference

Regulation of RelA (p65) function by the large subunit of replication factor C

21 September 2017

1 reference

https://api.crossref.org/works/10.1016%2FS1097-2765%2804%2900131-5

7 January 2021

Inhibition of NF-kappaB sensitizes human pancreatic carcinoma cells to apoptosis induced by etoposide (VP16) or doxorubicin

1 reference

https://api.crossref.org/works/10.1016%2FS1097-2765%2804%2900131-5

7 January 2021

The p65 (RelA) subunit of NF-kappaB interacts with the histone deacetylase (HDAC) corepressors HDAC1 and HDAC2 to negatively regulate gene expression

1 reference

https://api.crossref.org/works/10.1016%2FS1097-2765%2804%2900131-5

7 January 2021

Control of oncogenesis and cancer therapy resistance by the transcription factor NF-kappaB.

1 reference

https://api.crossref.org/works/10.1016%2FS1097-2765%2804%2900131-5

7 January 2021

Control of apoptosis by Rel/NF-kappaB transcription factors

1 reference

https://api.crossref.org/works/10.1016%2FS1097-2765%2804%2900131-5

7 January 2021

An essential role for NF-kappaB in preventing TNF-alpha-induced cell death

1 reference

https://api.crossref.org/works/10.1016%2FS1097-2765%2804%2900131-5

7 January 2021

Sequential DNA damage-independent and -dependent activation of NF-kappaB by UV

1 reference

https://api.crossref.org/works/10.1016%2FS1097-2765%2804%2900131-5

7 January 2021

Daunorubicin activates NFkappaB and induces kappaB-dependent gene expression in HL-60 promyelocytic and Jurkat T lymphoma cells

1 reference

https://api.crossref.org/works/10.1016%2FS1097-2765%2804%2900131-5

7 January 2021

The Rel/NF-kappaB family directly activates expression of the apoptosis inhibitor Bcl-x(L).

1 reference

https://api.crossref.org/works/10.1016%2FS1097-2765%2804%2900131-5

7 January 2021

Duration of nuclear NF-kappaB action regulated by reversible acetylation

1 reference

https://api.crossref.org/works/10.1016%2FS1097-2765%2804%2900131-5

7 January 2021

Acetylation of RelA at discrete sites regulates distinct nuclear functions of NF-kappaB.

1 reference

https://api.crossref.org/works/10.1016%2FS1097-2765%2804%2900131-5

7 January 2021

NF-kappaB blockade and oncogenic Ras trigger invasive human epidermal neoplasia.

1 reference

https://api.crossref.org/works/10.1016%2FS1097-2765%2804%2900131-5

7 January 2021

Immortalized embryonic mouse fibroblasts lacking the RelA subunit of transcription factor NF-kappaB have a malignantly transformed phenotype

1 reference

https://api.crossref.org/works/10.1016%2FS1097-2765%2804%2900131-5

7 January 2021

A critical evaluation of the mechanisms of action proposed for the antitumor effects of the anthracycline antibiotics adriamycin and daunorubicin

1 reference

https://api.crossref.org/works/10.1016%2FS1097-2765%2804%2900131-5

7 January 2021

NF-kappa B and Rel proteins: evolutionarily conserved mediators of immune responses

1 reference

https://api.crossref.org/works/10.1016%2FS1097-2765%2804%2900131-5

7 January 2021

The zinc finger domain of NEMO is selectively required for NF-kappa B activation by UV radiation and topoisomerase inhibitors.

1 reference

https://api.crossref.org/works/10.1016%2FS1097-2765%2804%2900131-5

7 January 2021

A regulator branches out

1 reference

https://api.crossref.org/works/10.1016%2FS1097-2765%2804%2900131-5

7 January 2021

Glucocorticoid receptor recruitment of histone deacetylase 2 inhibits interleukin-1beta-induced histone H4 acetylation on lysines 8 and 12.

1 reference

https://api.crossref.org/works/10.1016%2FS1097-2765%2804%2900131-5

7 January 2021

The pro- or anti-apoptotic function of NF-kappaB is determined by the nature of the apoptotic stimulus

1 reference

https://api.crossref.org/works/10.1016%2FS1097-2765%2804%2900131-5

7 January 2021

Phosphorylation meets ubiquitination: the control of NF-[kappa]B activity

1 reference

https://api.crossref.org/works/10.1016%2FS1097-2765%2804%2900131-5

7 January 2021

DNA damaging agents induce expression of Fas ligand and subsequent apoptosis in T lymphocytes via the activation of NF-kappa B and AP-1.

1 reference

https://api.crossref.org/works/10.1016%2FS1097-2765%2804%2900131-5

7 January 2021

CK2 Is a C-Terminal IκB Kinase Responsible for NF-κB Activation during the UV Response

1 reference

https://api.crossref.org/works/10.1016%2FS1097-2765%2804%2900131-5

7 January 2021

Post-activation turn-off of NF-kappa B-dependent transcription is regulated by acetylation of p65

1 reference

https://api.crossref.org/works/10.1016%2FS1097-2765%2804%2900131-5

7 January 2021

NF-kappaB in cancer: a marked target

1 reference

https://api.crossref.org/works/10.1016%2FS1097-2765%2804%2900131-5

7 January 2021

Inhibition of the DNA catenation activity of type II topoisomerase by VP16-213 and VM26

1 reference

https://api.crossref.org/works/10.1016%2FS1097-2765%2804%2900131-5

7 January 2021

Activators and target genes of Rel/NF-kappaB transcription factors

1 reference

https://api.crossref.org/works/10.1016%2FS1097-2765%2804%2900131-5

7 January 2021

p53- and Mdm2-Independent Repression of NF-κB Transactivation by the ARF Tumor Suppressor

1 reference

https://api.crossref.org/works/10.1016%2FS1097-2765%2804%2900131-5

7 January 2021

p53 represses cyclin D1 transcription through down regulation of Bcl-3 and inducing increased association of the p52 NF-kappaB subunit with histone deacetylase 1.

1 reference

https://api.crossref.org/works/10.1016%2FS1097-2765%2804%2900131-5

7 January 2021

Role of NF-κB in p53-mediated programmed cell death

1 reference

https://api.crossref.org/works/10.1016%2FS1097-2765%2804%2900131-5

7 January 2021

Two waves of nuclear factor kappaB recruitment to target promoters

1 reference

https://api.crossref.org/works/10.1016%2FS1097-2765%2804%2900131-5

7 January 2021

Modulation of NF-kappaB activity by exchange of dimers.

1 reference

https://api.crossref.org/works/10.1016%2FS1097-2765%2804%2900131-5

7 January 2021

Distinct roles of the Ikappa B kinase alpha and beta subunits in liberating nuclear factor kappa B (NF-kappa B) from Ikappa B and in phosphorylating the p65 subunit of NF-kappa B.

1 reference

https://api.crossref.org/works/10.1016%2FS1097-2765%2804%2900131-5

7 January 2021

TRAIL and inhibitors of apoptosis are opposing determinants for NF-kappaB-dependent, genotoxin-induced apoptosis of cancer cells

1 reference

https://api.crossref.org/works/10.1016%2FS1097-2765%2804%2900131-5

7 January 2021

IkappaB kinase-independent IkappaBalpha degradation pathway: functional NF-kappaB activity and implications for cancer therapy

1 reference

https://api.crossref.org/works/10.1016%2FS1097-2765%2804%2900131-5

7 January 2021

Regulation of the transcriptional activity of the nuclear factor-kappaB p65 subunit.

1 reference

https://api.crossref.org/works/10.1016%2FS1097-2765%2804%2900131-5

7 January 2021

TNF- and cancer therapy-induced apoptosis: potentiation by inhibition of NF-kappaB

1 reference

https://api.crossref.org/works/10.1016%2FS1097-2765%2804%2900131-5

7 January 2021

Activation of nuclear factor-kappaB during doxorubicin-induced apoptosis in endothelial cells and myocytes is pro-apoptotic: the role of hydrogen peroxide

1 reference

https://api.crossref.org/works/10.1016%2FS1097-2765%2804%2900131-5

7 January 2021

Transcriptional cross talk between NF-kappaB and p53.

1 reference

https://api.crossref.org/works/10.1016%2FS1097-2765%2804%2900131-5

7 January 2021

The phosphorylation status of nuclear NF-kappa B determines its association with CBP/p300 or HDAC-1

1 reference

https://api.crossref.org/works/10.1016%2FS1097-2765%2804%2900131-5

7 January 2021

10.1016/S1097-2765(04)00131-5

Identifiers

DOI

1 reference

21 September 2017

1 reference

PubMed ID

15053878